PACT (strumento di coordinamento delle attività pubbliche)

PACT (strumento di coordinamento delle attività pubbliche)

PACT (strumento di coordinamento delle attività pubbliche)

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

PACT

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment RMOA Regulatory risk management
 
3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropyl ether 407-980-2 80844-07-1 - - - 1 - 1 - - Details
Amines, C11-14-branched alkyl, monohexyl and dihexyl phosphates 279-632-6 80939-62-4 - - 1 - - - - - Details
5-tert-butyl-2,4,6-trinitro-m-xylene 201-329-4 81-15-2 - - - - - - 1 - Details
Cholic acid 201-337-8 81-25-4 - - 1 - - - - - Details
Perylene-3,4:9,10-tetracarboxydiimide 201-344-6 81-33-4 1 1 1 - - - - - Details
N-(4-amino-9,10-dihydro-3-methoxy-9,10-dioxo-1-anthryl)-4-methylbenzenesulphonamide 201-369-2 81-68-5 - - 1 - - - - - Details
6,15-dihydroanthrazine-5,9,14,18-tetrone 201-375-5 81-77-6 - - 1 - - - - - Details
Warfarin 201-377-6 81-81-2 - - - - - 1 - - Details
.alpha.-D-Glucopyranosyl bromide, 2,3,4,6-tetrakis(2,2-dimethylpropanoate) 686-241-8 81058-27-7 - - 1 - - - - - Details
Norflurane 212-377-0 811-97-2 - - 1 - - - - - Details
Bismuth citrate 212-390-1 813-93-4 - - 2 - - - - - Details
Cobalt oxalate 212-409-3 814-89-1 - - 2 - - - - - Details
1-(2,6-bis(4-tolyl)-1,3-dioxano(5,4-d)-1,3-dioxan-4-yl)ethane-1,2-diol
CLEARLITE NU 005; DISORBENE M; GENISET MD; GLC NU 005; MILLAD 3940; NU 005
402-950-5 81541-12-0 - - 1 - - - - - Details
clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one 617-258-0 81777-89-1 - - - - - 1 - - Details
2-(2,4-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one; bixlozone 701-330-4 81777-95-9 - - - - - 1 - - Details
Dibutyltin oxide 212-449-1 818-08-6 - - 2 - - 1 - - Details
2-hydroxyethyl acrylate 212-454-9 818-61-1 - - 2 - - - - - Details
N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-2-[(2-methoxyphenyl)azo]-3-oxobutyramide 279-914-9 82199-12-0 - - 1 - - - - - Details
Hexamethylene diisocyanate 212-485-8 822-06-0 - - - - 1 - - - Details
4-methylimidazole 212-497-3 822-36-6 - - - - - 1 - - Details
(E)-3-methyl-5-cyclopentadecen-1-one 429-900-5 82356-51-2 - - 1 - - - - - Details
2-Propenoic acid, 2-methyl-, 7-oxabicyclo[4.1.0]hept-3-ylmethyl ester 688-147-2 82428-30-6 - - 1 - - - - - Details
1,2,3-Propanetricarboxylic acid, 2-(1-oxobutoxy)-, 1,2,3-trihexyl ester 413-890-4 82469-79-2 - - 1 - - - - - Details
Sodium 4-hydroxybenzenesulphonate 212-550-0 825-90-1 - - 1 - - - - - Details
4-(butoxymethyl)-2-methoxyphenol 444-010-7 82654-98-6 - - 1 - - - - - Details
(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate;bifenthrin (ISO) 617-373-6 82657-04-3 - - - - - 1 - - Details
[1,1'-Bicyclohexyl]-4-one,4'-propyl-, 617-391-4 82832-73-3 - - 1 - - - - - Details
Bis(trimethoxysilylpropyl)amine 280-084-5 82985-35-1 - - 1 - - - - - Details
Acenaphthene 201-469-6 83-32-9 - - - - 1 - - - Details
diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide 617-446-2 83164-33-4 - - - - - 1 - - Details
Ametryn 212-634-7 834-12-8 - - 1 - - - - - Details
Bis(2,4,4-trimethylpentyl)phosphinic acid 280-445-7 83411-71-6 - - 2 - - - - - Details
2,9-bis(p-methoxybenzyl)anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone 280-472-4 83524-75-8 - - 1 - - - - - Details
Di-L-para-menthene 417-870-6 83648-84-4 - - 1 - - - - - Details
4,4'-methylenedi-o-toluidine 212-658-8 838-88-0 - - - - - - 1 - Details
2-Ethylhexyl trans-4-methoxycinnamate 629-661-9 83834-59-7 1 1 1 1 - - - - Details
Benzoic acid, 2-hydroxy-, mono-C>13-alkyl derivs., calcium salts (2:1) 281-018-8 83846-43-9 - - 4 - - - - - Details
2-butyl-4-chloro-5-formylimidazole 410-260-0 83857-96-9 - - 1 - - - - - Details
Tris(2-hydroxyethyl)-1,3,5-triazinetrione 212-660-9 839-90-7 - - 2 - - - - - Details
2-ethylanthraquinone 201-535-4 84-51-5 - - 1 - - - - - Details
Dicyclohexyl phthalate 201-545-9 84-61-7 1 - 1 2 1 1 1 - Details
Anthraquinone 201-549-0 84-65-1 - - 3 - - 1 - - Details
Diethyl phthalate 201-550-6 84-66-2 1 - 2 1 - - - - Details
Diisobutyl phthalate 201-553-2 84-69-5 - - - - - 1 1 - Details
Dibutyl phthalate 201-557-4 84-74-2 - 1 - - - - 1 - Details
Dihexyl phthalate 201-559-5 84-75-3 - - - - - 1 1 - Details
Dimethyl naphthalene-2,6-dicarboxylate 212-661-4 840-65-3 - - 1 - - - - - Details
Trisodium hydrogen [2-[[α-[[3-[[4-chloro-6-[ethyl[3-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulphophenyl]azo]benzyl]azo]-4-sulphobenzoato(6-)]cuprate(4-) 281-889-4 84057-71-6 - - 1 - - - - - Details
Formaldehyde, reaction products with ethylenediamine 281-928-5 84066-92-2 - - 2 - - - - - Details
4-(1,1-dimethylethyl)cyclohexyl acrylate 282-104-8 84100-23-2 - - 1 - - - - - Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.